Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333922 | 1.00 | CYP3A4 (0.38) | CYP3A4TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL28989799 | 0.97 | ADRA2A (0.36) | CYP3A4TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL27291641 | 0.94 | ADRA2A (0.40) | ADRA2AADRA2BADRA2CMTNR1AMTNR1B | |
| SCHEMBL718791 | 0.82 | TSHR (0.40) | TSHR | |
| SCHEMBL30739530 | 0.82 | TSHR (0.40) | TSHR | |
| SCHEMBL829452 | 0.78 | TSHR (0.43) | TSHRADRA2AADRA2C | |
| SCHEMBL28646514 | 0.74 | KDM4E (0.41) | CYP3A4TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL25381760 | 0.73 | PDPK1 (0.40) | — | |
| SCHEMBL334090 | 0.73 | MTNR1B (0.35) | CYP3A4TSHRADRA2AADRA2BADRA2C | |
| SCHEMBL5013339 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667593-B2 | Compounds, including nonsymmetrical polyaromatic hydrocarbons, and methods | The Florida State University Research Foundation, Inc. (US) | 2023-06-06 | — | — | US | disclosed |
| US-20230106858-A1 | COMPOUNDS, INCLUDING NONSYMMETRICAL POLYAROMATIC HYDROCARBONS, AND METHODS | The Florida State University Research Foundation, Inc. | 2023-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230106858-A1 | COMPOUNDS, INCLUDING NONSYMMETRICAL POLYAROMATIC HYDROCARBONS, AND METHODS | AHR, ARNT, PAH | CYP3A4 35/4885TSHR 4535/4885ADRA2A 2806/4885 |
| US-11667593-B2 | Compounds, including nonsymmetrical polyaromatic hydrocarbons, and methods | AHR, ARNT, PAH | CYP3A4 35/4885TSHR 4535/4885ADRA2A 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.